Disproportionate high incidence of invasive cervical cancer as an AIDS- indicative disease among young women in Catalonia, Spain

Sexually Transmitted Diseases

Volumn 26, Issue 9, 1999, Pages 500-503

  Vall Mayans, Martí ^a,b   Maguire, Andrew ^a   Miret, Montserrat ^a   Casabona, Jordi ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b U Med Trop Salut Intl Drassanes   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIDS RELATED COMPLEX; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CANCER SUSCEPTIBILITY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; SPAIN; UTERINE CERVIX CANCER;

ADULT; AGE FACTORS; COST-BENEFIT ANALYSIS; FEMALE; HIV INFECTIONS; HUMANS; MASS SCREENING; MIDDLE AGED; NEOPLASM INVASIVENESS; SPAIN; STREET DRUGS; UTERINE CERVICAL NEOPLASMS;

EID: 0344563573     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199910000-00003     Document Type: Article

References (23)

1. European Centre for the Epidemiological Monitoring of AIDS. HIV/ AIDS Surveillance in the European Union: Quarterly Report no. 38, March 31, 1997.
2. Spanish National Health Plan. Epidemiology of AIDS in Spain, 1996 (in Spanish). Madrid: Ministry of Health and Consumer Affairs; 1997.
3. Schäfer A, Friedmann W, Mielke M, Schwartländer B, Koch MA. The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosupression. Am J Obstet Gynecol 1991;164:593-9.
4. Maiman M, Fruchter RG, Guy L, Cuthill S, Levine P, Serur E. Human immunodeficiency virus infection and invasive cervical cancer. Cancer 1993;71:402-6.
5. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(No. RR-17):1-19.
6. Cancer Incidence in Five continents, Vol. VI. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds. Lyon International Agency for Research on Cancer, 1992.
7. Vall Mayans M, Maya A, Matas L, Casabona J, VIHNADO Group. Prevalence of maternal HIV infection in Catalonia, Spain based on unlinked anonymous testing of newborn babies (1994). Med Clin (Barc) 1998;110:128-31. (In Spanish).
8. Rodés A, Vall M, Casabona J, Nuez M, Rabella N, Mitrani L. Prevalence of HIV infection and their associated risk behaviors among street-recruited drug users. Med Clin (Barc) 1998;111:372-7. (In Spanish).
9. Last J, ed. International Epidemiological Association. A Dictionary of Epidemiology, 2nd ed. NY: Oxford University Press, 1988,
10. Casabona J, Vall M, Rodés A, Blanch C, Miret M. Estimation of the global HIV prevalence using data from the HIV surveillance system in Catalonia (abstract CO4-1). (In Spanish). Presented at IV National Congress on AIDS, Valencia, Spain, April 1-3, 1997. Publicación Oficial Seisida 1997;8(S1):10.
11. Rothman KJ. Modern Epidemiology. Boston: Little, Brown and Co., 1986.
12. Blanch Mur C, Vall Mayans M, Mompart Penina A, Pérez Albarracín G, Casabona J. The demografic impact of AIDS among the young population in Catalonia, 1981-93. Med Clin (Barc) 1995;105:528-31. (In Spanish).
13. Serraino D, Napoli PA, Zaccarelli M, Alliegro MB, Pezzotti P, Rezza G. High frequency of invasive cervical cancer among female injecting drug users with AIDS in Italy (letter). AIDS 1996;10:1041-55.
14. Olivero OA, Anderson LM, Diwan BA, et al. AZT is a genotoxic transplacental carcinogen in animal models (abstract 52). Presented at the National AIDS Malignancy Conference, Bethesda, Maryland, April 28-30, 1997. J AIDS 1997;14:A29.
15. IARC Working Group on the evaluation of carcinogenic risks to humans. Studies in HIV-infected persons. In: Human Papillomaviruses, IARC Monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC, 1995;(64):212-32.
16. De Sanjosé S, Palacio V, Tafur L, et al. Prostitution, HIV and cervical neoplasia: a survey in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2:531-5.
17. Maiman M, Fruchter R, Clark M, Arrastia CD, Matthews R, Jason Gates E. Cervical cancer as an AIDS-defining illness. Obstet Gynecol 1997;89:76-80.
18. Weber TJ, Chin K, Sidhu JS, Jansen RS, the Sentinel Hospital Surveillance System for HIV Infection Principal Investigators. Prevalence of ICC among HIV infected and uninfected hospital patients (abstract 717). Presented at the 5th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, February 1-5, 1998.
19. Mandelblatt JS, Fahs M, Garibaldi K, Senie RT, Peterson HB. Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions. AIDS 1992; 6:173-8.
20. Department of Health and Social Security. Health Plan for Catalonia 1996-1998. Generalitat de Catalunya, Barcelona 1997:268. (In Catalan).
21. Barlett JG. 1998 Medical Management of HIV Infection. Baltimore: Johns Hopkins University, Department of Infectious Diseases, 1998: 28-31.
22. Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med 1999;130:97-107.
23. Centers for Disease Control and Prevention. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morb Mort Wkly Rep 1997;46(RR-12):1-46.